Publicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria Gregorio Marañón (18)

2024

  1. Hepatic hemodynamic study: More than just HVPG measurement

    Gastroenterologia y Hepatologia

2023

  1. Portal hypertension increases the risk of hepatic decompensation after 90Yttrium radioembolization in patients with hepatocellular carcinoma: a cohort study

    Therapeutic Advances in Gastroenterology, Vol. 16

2022

  1. Hepatitis C eradication improves cognitive function in patients with or without cirrhosis: A prospective real-life study

    European Journal of Neurology, Vol. 29, Núm. 2, pp. 400-412

  2. Non-pharmacologic direct cost of a simplified strategy with glecaprevir/pibrentasvir for 8 weeks in naïve non-cirrhotic patients with hepatitis C implemented in clinical practice. The Just SIMPLE Study

    Gastroenterologia y Hepatologia, Vol. 45, Núm. 5, pp. 342-349

2020

  1. A Model Based on Noninvasive Markers Predicts Very Low Hepatocellular Carcinoma Risk After Viral Response in Hepatitis C Virus–Advanced Fibrosis

    Hepatology, Vol. 72, Núm. 6, pp. 1924-1934

  2. Plasma metabolomic fingerprint of advanced cirrhosis stages among HIV/HCV-coinfected and HCV-monoinfected patients

    Liver International, Vol. 40, Núm. 9, pp. 2215-2227

  3. Prevalence, features and predictive factors of liver nodules in Fontan surgery patients: The VALDIG Fonliver prospective cohort

    Journal of Hepatology, Vol. 72, Núm. 4, pp. 702-710

2018

  1. Fungaemia caused by rare yeasts: Incidence, clinical characteristics and outcome over 10 years

    Journal of Antimicrobial Chemotherapy

2017

  1. Left ventricular systolic function is associated with sympathetic nervous activity and markers of inflammation in cirrhosis

    Hepatology, Vol. 65, Núm. 6, pp. 2019-2030

  2. Similar effectiveness of direct-acting antiviral against hepatitis C virus in patients with and without HIV infection

    AIDS, Vol. 31, Núm. 9, pp. 1253-1260

2016

  1. Determinants of platelet count are different in patients with compensated and decompensated cirrhosis

    Liver International, Vol. 36, Núm. 2, pp. 232-239

  2. Liver Support With Albumin Dialysis Reduces Hepatitis C Virus Viremia and Facilitates Antiviral Treatment of Severe Hepatitis C Virus Recurrence After Liver Transplantation

    Therapeutic Apheresis and Dialysis, Vol. 20, Núm. 2, pp. 189-196

2015

  1. Antifungal stewardship in a tertiary-care institution: A bedside intervention

    Clinical Microbiology and Infection, Vol. 21, Núm. 5, pp. 492.e1-492.e9

  2. Characteristic haemodynamic changes of cirrhosis may influence the diagnosis of portopulmonary hypertension

    Liver International, Vol. 35, Núm. 2, pp. 353-361

2014

  1. Evaluation of antifungal use in a tertiary care institution: Antifungal stewardship urgently needed

    Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 7, pp. 1993-1999

  2. Prediction of liver complications in patients with hepatitis C virus-related cirrhosis with and without HIV coinfection: Comparison of hepatic venous pressure gradient and transient elastography

    Clinical Infectious Diseases, Vol. 58, Núm. 5, pp. 713-718

2013

  1. Prognostic value of hepatic venous pressure gradient in patients with compensated chronic hepatitis C-related cirrhosis

    Scandinavian Journal of Gastroenterology, Vol. 48, Núm. 4, pp. 487-495

  2. Update on the use of direct-acting antiviral agents for the treatment of chronic hepatitis C virus infection.

    Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia, Vol. 26, Núm. 3, pp. 189-192